ORACLE INVESTMENT MANAGEMENT INC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 11 filers reported holding SOLENO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ORACLE INVESTMENT MANAGEMENT INC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$394,000
-17.1%
2,132,0000.0%0.12%
+27.7%
Q1 2022$475,000
-45.7%
2,132,0000.0%0.09%
-24.2%
Q4 2021$874,000
-55.7%
2,132,0000.0%0.12%
-49.4%
Q3 2021$1,971,000
-18.9%
2,132,0000.0%0.24%
-26.9%
Q2 2021$2,430,000
-9.5%
2,132,0000.0%0.34%
-16.7%
Q1 2021$2,686,000
-62.1%
2,132,000
-41.9%
0.40%
-54.7%
Q4 2020$7,084,000
-23.1%
3,670,3840.0%0.89%
-26.9%
Q3 2020$9,213,000
+13.1%
3,670,3840.0%1.21%
+17.4%
Q2 2020$8,148,000
-11.6%
3,670,384
-5.2%
1.03%
-62.2%
Q1 2020$9,212,000
-19.1%
3,870,6270.0%2.74%
+28.1%
Q4 2019$11,380,000
+96.0%
3,870,6270.0%2.14%
+49.6%
Q3 2019$5,806,000
-45.6%
3,870,627
+1.5%
1.43%
-37.8%
Q2 2019$10,678,000
+35.9%
3,813,5580.0%2.30%
+37.4%
Q1 2019$7,856,000
+24.7%
3,813,558
+3.5%
1.67%
-14.4%
Q4 2018$6,298,000
+19.6%
3,683,195
+51.1%
1.95%
+69.4%
Q3 2018$5,266,000
-7.7%
2,438,0600.0%1.15%
-16.4%
Q2 2018$5,705,000
+31.8%
2,438,060
+2.1%
1.38%
+31.5%
Q1 2018$4,330,000
+0.7%
2,388,0600.0%1.05%
+22.8%
Q4 2017$4,299,0002,388,0600.85%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$25,757,0005.51%
CVI Holdings, LLC 1,550,960$3,893,0001.58%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$9,213,0001.21%
Trellus Management Company, LLC 416,432$1,045,0001.07%
Consonance Capital Management LP 3,040,000$7,630,0000.93%
AWM Investment Company, Inc. 1,550,000$3,890,0000.64%
Nantahala Capital Management 7,426,368$18,640,0000.57%
Granite Point Capital Management, L.P. 2,200,000$5,522,0000.30%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,226,753$8,099,0000.15%
Greylin Investment Management, Inc 134,195$337,0000.09%
View complete list of SOLENO THERAPEUTICS INC shareholders